£1 million appeal to save life of inspector’s son
15 September 2026
A £1 million fund-raising appeal has been launched to help save the life of the six-year-old son of a West Midlands Police officer.
Partaap Singh was diagnosed with an extremely rare, terminal, neurodegenerative disease in January this year prompting his devastated Mum, Inspector Gurbinder Kaur, to set up a Go Fund Me page in the hope of funding pioneering treatment.
Gurbinder explains: “Partaap is our brave, bright, confident six-year-old who lights up every room he walks into. He makes friends effortlessly with his sunny nature and beautiful smile, and he is always the first to help anyone who needs it. He is the most wonderful big brother to his brother, and is always looking out for him.
Struggling
“Early last year, we noticed small things that didn’t feel right. He began struggling to walk long distances, to stand up from sitting, and to climb stairs. He fell often, for no clear reason. What followed were months of hospital visits, tests, and endless worry. Through it all, Partaap was courageous, patient, and unbelievably strong.
“In January, our world shattered. His genetic tests came back, and we were told he has Juvenile ALS (amyotrophic lateral sclerosis), also known as MND (motor neuron disease). The gene variant causing his illness, SPTLC2, is so rare that only 40 – 50 children worldwide are believed to have it. No one knows how quickly it will progress in him, or how much time we have left. As parents, hearing this felt like the ground disappeared beneath us.”
There is no cure for ALS. It destroys motor neurons in the brain and spinal cord, slowly taking away the ability to walk, move, speak, swallow and eventually breathe. In adults, ALS is usually diagnosed around age 55+ and, even then, most survive only two to five years. In children, it is so rare that very little is known and there are no clinical trials for Partaap’s gene variant.
Partaap currently struggles to walk more than a few minutes, to climb stairs, to balance and to stand up from sitting. He falls often and his limbs are weak. But he is still fiercely independent insisting on walking when he can, and playing football and tag with his brother.
Gurbinder says: “We refuse to give up. When doctors told us there was no cure, no treatment, and that we should focus on palliative care, we simply couldn’t accept that. Not for our child. Not without trying everything. That’s when we turned to clinical research where new therapies come to light.
Devastating
“One of the most promising approaches for rare genetic diseases is antisense oligonucleotides (ASOs), targeted treatments that can reduce harmful proteins or ‘switch off’ faulty gene messages. In Partaap’s case, his gene variant causes an overproduction of sphingolipids, which is driving the disease.
“An ASO for SPTLC2 related ALS has never been attempted before. But we are assembling a team to try to create a bespoke ASO for Partaap that could slow or even stop the progression of this devastating disease.”
The family are working with Jeff Milton, a scientist and biotechnology entrepreneur who has dedicated his career to making precision medicines accessible for people with rare neurodegenerative diseases.
“Jeff is helping us build a team for Partaap, but speed is everything. Every month that passes, we risk losing more of our son’s abilities,” Gurbinder adds, “Because this disease is so rare, no one knows how aggressive it will be. To move quickly, we need to raise around £1 million to cover the costs of designing, developing and delivering a potential ASO treatment - something that has never been done before for this gene.”
Comfortable
Even if successful, ASOs are not a one-time cure. They must be administered repeatedly every few months, meaning long-term financial challenges.
On top of this, the family are facing ongoing care costs: therapies, specialised equipment, home adaptations, travel and everything needed to keep Partaap safe, comfortable, and able to enjoy his childhood.
“We are giving everything we have, but we cannot do this alone. Every donation, every share, every bit of support means the world to us. Time is absolutely critical. Please help us fight for our son’s life, and help us turn his story into one of hope, courage and possibility,” Gurbinder concludes.
